Jorge Pedro Santos Radeck D Silva filed Form 144 to notify SEC of plan to sell 150000 units of MoonLake Immunotherapeutics Inc. securities around 2026-04-10, with aggregate market value of $2,787,000.00. The total outstanding units is 71727875.0. The amount planned to be sold represents 0.21% of total outstanding units...

PIYUSH SEVALIA filed Form 144 to notify SEC of plan to sell 1247 units of SiTime Corporation securities around 2026-04-10, with aggregate market value of $507,142.43. The total outstanding units is 26299915.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 month...

Shetty Reshma P. filed Form 144 to notify SEC of plan to sell 124727 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-04-10, with aggregate market value of $802,530.94. The total outstanding units is 49941878.0. The amount planned to be sold represents 0.25% of total outstanding units; Recent transactions...

SIDDHARTH SITARAM filed Form 144 to notify SEC of plan to sell 2427 units of DOXIMITY, INC. securities around 2026-04-10, with aggregate market value of $51,185.43. The total outstanding units is 133811547.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months...

Smith Dylan C filed Form 144 to notify SEC of plan to sell 10280 units of BOX INC securities around 2026-03-10, with aggregate market value of $227,126.11. The total outstanding units is 138449581.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months include:...

Van Orden John L filed Form 144 to notify SEC of plan to sell 8000 units of VILLAGE SUPER MARKET INC securities around 2026-04-10, with aggregate market value of $354,480.00. The total outstanding units is 10626925.0. The amount planned to be sold represents 0.08% of total outstanding units; ...

Van Orden John L filed Form 144 to notify SEC of plan to sell 8000 units of VILLAGE SUPER MARKET INC securities around 2026-04-10, with aggregate market value of $354,480.00. The total outstanding units is 10626925.0. The amount planned to be sold represents 0.08% of total outstanding units; ...

Velaga S. Ram filed Form 144 to notify SEC of plan to sell 8000 units of Broadcom Inc. securities around 2026-04-10, with aggregate market value of $2,964,179.00. The total outstanding units is 4734668184.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months ...

THE WOOD REVOCABLE TRUST U/A DTD 12/01/2017 filed Form 144 to notify SEC of plan to sell 50000 units of ROKU, INC. securities around 2026-04-10, with aggregate market value of $5,002,000.00. The total outstanding units is 130717715.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent tra...

KRISHNASWAMY YELESWARAM filed Form 144 to notify SEC of plan to sell 500 units of Rapport Therapeutics, Inc. securities around 2026-04-10, with aggregate market value of $17,110.00. The total outstanding units is 47792943.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions ...

This is a Form 3 filing for Paul Miele, Senior Vice President and Chief Commercial Officer of Accuray Incorporated (ticker: ARAY). The filing reports that as of April 6, 2026, Mr. Miele does not beneficially own any securities of the company. The document includes a power of attorney executed on April 6, 2026, authoriz...

Lawrence Bernard Gozlan, a director at ALTERITY THERAPEUTICS LTD (ATHE), has filed an initial statement of beneficial ownership. The filing, dated April 10, 2026, details holdings through Montoya Pty Ltd <Buttercup A/C>. Gozlan holds 4,545,555 ordinary shares indirectly. Additionally, he holds 1,515,152 listed options ...

This Form 3 filing reports that Julian Michael Babarczy, a director of Alterity Therapeutics Ltd (ATHE), has no securities ownership in the company as of April 10, 2026. The filing indicates that Babarczy serves as a director but does not hold any ownership position in the company's securities. The filing was submitted...

This filing reports a change in beneficial ownership of securities for Peter Ashley Marks, a director at ALTERITY THERAPEUTICS LTD. The changes involve both derivative and non-derivative holdings. Specifically, there are listed options expiring on February 26, 2027, and unlisted options expiring on December 30, 2027. T...

This filing details restricted stock units (RSUs) granted to Jin Cao, Chief Accounting Officer of Ascentage Pharma Group International. Each RSU represents a contingent right to one Ordinary Share, vesting in four equal increments on November 26th of 2026, 2027, 2028, and 2029. The filing also includes a Power of Attor...

This filing details a Power of Attorney granted by Thomas A. Zalewski, Chief Legal Officer of Aquestive Therapeutics, Inc., to Hillary T. Yegen, Ellen S. Knarr, and Christopher M. Rogers. The attorneys-in-fact are authorized to prepare and execute necessary documents for electronic SEC filings, including Forms 3, 4, 5,...

This filing reports initial beneficial ownership of securities by Thierry Bernard, a director at BRUKER CORP. The report, filed on April 7, 2026, pertains to the period ending April 1, 2026. Mr. Bernard resides at 40 Manning Rd, Billerica, MA 01821. As a director, this filing is an initial disclosure of his holdings. T...

This filing is an initial report of beneficial ownership (Form 3) for Jorge Francisco Betzhold, who is a director at BUENAVENTURA MINING CO INC (BVN). The report indicates that Mr. Betzhold has no securities owned as of April 10, 2026. The filing details his non-US address in Pombal, Portugal. This form is typically fi...

This Form 3 filing reports that Julian Michael Babarczy, a director of Alterity Therapeutics Ltd (ATHE), has no securities ownership in the company as of April 10, 2026. The filing indicates that Babarczy serves as a director but does not hold any ownership position in the company's securities. The filing was submitted...

This filing reports initial beneficial ownership of securities by Thierry Bernard, a director at BRUKER CORP. The report, filed on April 7, 2026, pertains to the period ending April 1, 2026. Mr. Bernard resides at 40 Manning Rd, Billerica, MA 01821. As a director, this filing is an initial disclosure of his holdings. T...

This filing is an initial report of beneficial ownership (Form 3) for Jorge Francisco Betzhold, who is a director at BUENAVENTURA MINING CO INC (BVN). The report indicates that Mr. Betzhold has no securities owned as of April 10, 2026. The filing details his non-US address in Pombal, Portugal. This form is typically fi...

This is a Form 3 filing by Shaoyu Yan, who has become a director of BioLineRx Ltd. (NASDAQ: BLRX). The filing represents Yan's initial statement of beneficial ownership of securities in the company, as required when a person becomes a director, officer, or beneficial owner of more than 10% of a class of equity securiti...

This filing reports the initial beneficial ownership of Jianjun Gao, who is a director at Bon Natural Life Ltd. The reporting owner, registered as GAO JIANJUN, resides in Xi'an, China. The document, a Form 3, indicates that the reporting owner has no securities owned as of the period of report, April 2, 2026. The signa...

This filing reports on the ownership of Bon Natural Life Ltd. (BON) by Jing Liu. Jing Liu holds 2,004,427 Class B ordinary shares, which are convertible into 80,177 Class A ordinary shares. The filing also indicates that Jing Liu directly owns 1496 Class A ordinary shares. Additionally, Jing Liu holds a derivative secu...

This filing reports the initial beneficial ownership of securities by WENJUAN CHEN, Chief Marketing Officer of Bon Natural Life Ltd. The filing indicates that Ms. Chen, through Lavender Oil Limited, beneficially owns 80 Class A Ordinary Shares. The nature of ownership is indirect, as detailed in footnote 1. The reporti...